[{"AccountsPayableCurrent_0_Q1_USD":264000000.0,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1_Q1_USD":-38000000.0,"NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1_Q1_USD":-1117000000.0,"NetCashProvidedByUsedInDiscontinuedOperations_1_Q1_USD":-40000000.0,"LitigationReserve_0_Q1_USD":30000000.0,"LIFOInventoryAmount_0_Q1_USD":90000000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_0_Q1_USD":73000000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q1_USD":44000000.0,"LiabilitiesCurrent_0_Q1_USD":2875000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":9642000000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1_Q1_USD":1300000000.0,"InventoryWorkInProcessAndRawMaterials_0_Q1_USD":573000000.0,"InventoryNet_0_Q1_USD":924000000.0,"InventoryLIFOReserve_0_Q1_USD":1000000.0,"InventoryGross_0_Q1_USD":1029000000.0,"InventoryFinishedGoods_0_Q1_USD":399000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-15000000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":-141000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":33000000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_1_Q1_USD":769000000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":70000000.0,"InventoryNoncurrent_0_Q1_USD":104000000.0,"NetIncomeLoss_1_Q1_USD":399000000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"OtherAssetsCurrent_0_Q1_USD":782000000.0,"UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_1_Q1_USD":29000000.0,"StockholdersEquity_0_Q1_USD":4722000000.0,"ShareBasedCompensation_1_Q1_USD":11000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":382000000.0,"Revenues_1_Q1_USD":1506000000.0,"RestructuringReserve_0_Q1_USD":12000000.0,"RestructuringCharges_1_Q1_USD":1000000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":67000000.0,"RepaymentsOfShortTermDebt_1_Q1_USD":566000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":986000000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":0.0,"PensionAndOtherPostretirementBenefitExpense_1_Q1_USD":18000000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":38000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1847000000.0,"OtherInventorySupplies_0_Q1_USD":57000000.0,"OtherComprehensiveIncomeLossTax_1_Q1_USD":3000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-68000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-68000000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q1_USD":-65000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-66000000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":2000000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-52000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":40000000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":4000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":72000000.0,"DeferredIncomeTaxesAndOtherAssetsNoncurrent_0_Q1_USD":535000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":591000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":331000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_1_Q1_USD":204000000.0,"CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_1_Q1_USD":0.0,"CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_1_Q1_USD":-244000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_0_Q1_USD":161000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":141000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":141000000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q1_USD":120000000.0,"AssetsCurrent_0_Q1_USD":2977000000.0,"Assets_0_Q1_USD":9642000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":14000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":11000000.0,"AdjustmentForAmortization_1_Q1_USD":20000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-689000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":817000000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":288000000.0,"AccountsReceivableSale_1_Q1_USD":181000000.0,"AccountsReceivableNetCurrent_0_Q1_USD":1010000000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-25000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":253516000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":125000000.0,"Depreciation_1_Q1_USD":18000000.0,"IncomeTaxesPaid_1_Q1_USD":18000000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q1_USD":0.02,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q1_USD":0.02,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q1_USD":4000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q1_USD":1.56,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q1_USD":1.56,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":467000000.0,"IncomeLossFromContinuingOperations_1_Q1_USD":395000000.0,"Goodwill_0_Q1_USD":4603000000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-7000000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":482000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":2000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":91000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_1_Q1_USD":-1000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-13000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.155,"EarningsPerShareDiluted_1_Q1_USD":1.58,"EarningsPerShareBasic_1_Q1_USD":1.58,"DueToRelatedPartiesCurrent_0_Q1_USD":1520000000.0,"DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_0_Q1_USD":20000000.0,"DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_0_Q1_USD":59000000.0,"DefinedBenefitPlanServiceCost_1_Q1_USD":1000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":253516000.0,"Ticker":"OGN","CIK":"1821825","name":"ORGANON & CO.","OfficialName":"Organon & Co. Common Stock ","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8610982227.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210621"}]